STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Lyra Therapeutics, Inc.

Filed

June 2, 2023

Period of Report

May 31, 2023

Accession Number

0001062993-23-012744